Participation of mTOR in the regulation of multidrug resistance of tumor cells

Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

Volumn 3, Issue 2, 2009, Pages 184-189

  Scherbakova, E A ^a   Rybalkina, E Yu ^a   Stromskaya, T P ^a   Stavrovskaya, A A ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

ABC transporters; mTOR protein; Multidrug resistance; Rapamycin; Tumor cells

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; DOXORUBICIN; GLYCOPROTEIN P; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RAPAMYCIN; VINBLASTINE;

ARTICLE; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG INTERACTION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSLATION REGULATION; TUMOR CELL;

EID: 67650340461     PISSN: 19907478     EISSN: 19907494     Source Type: Journal    
DOI: 10.1134/S1990747809020111     Document Type: Article

References (23)

1. Stavrovskaya, A.A., Kantserogenez (Carcinogenesis), Moscow, Meditsina, 2004, pp. 558-574.
2. Scherbakova, E.A., Stromskaya, T.P., Rybalkina, E.Yu., and Stavrovskaya, A.A., Influence of Human Tumor Suppressor PTEN on Sensitivity of Malignant Cells to Anticancer Drugs, Biologicheskie Membrany (Rus.), 2007, vol. 24(2), pp. 143-150.
3. Scherbakova, E.A., Stromskaya, T.P., Rybalkina, E.Yu., Kalita, O.V., and Stavrovskaya, A.A., Role of PTEN Protein in Multidrug Resistance of Prostate Cancer Cells, Molec. Biologia (Rus.), 2008, vol. 42(3), pp. 430-435.
4. Arceci, R.J., Stieglitz, K., and Bierer, B.E., Immunosuppressants FK506 and Rapamycin Function As Reversal Agents of the Multidrug Resistance Phenotype, Blood, 1992, vol. 80(6), pp. 1528-1536.
5. Yacyshyn, B.R., Bowen-Yacyshyn, M.B., and Pilarski, L.M., Inhibition by Rapamycin of P-Glycoprotein 170-Mediated Export from Normal Lymphocytes, Scand. J. Immunol., 1996, vol. 43(4), pp. 449-455.
6. Wu, C., Wangpaichitr, M., Feun, L., Kuo, M.T., Robles, C., Lampidis, T., and Savaraj, N. Overcoming Cisplatin Resistance by mTOR Inhibitor in Lung Cancer, Mol. Cancer., 2005, vol. 4(1), p. 25.
7. Stone, K.R., Mickey, D.D., Wunderli, H., Mickey, G.H., and Paulson, D.F., Isolation of a Human Prostate Carcinoma Cell Line (DU 145), Int. J. Cancer, 1978, vol. 21, pp. 274-281.
8. Kaighn, M.E., Lechner, J.F., Narayan, K.S., and Jones, L.W., Prostate Carcinoma: Tissue Culture Cell Lines, Natl. Cancer Inst. Monogr., 1978, vol. 49, pp. 17-21.
9. Park, S.W., Lomri, N., Simeoni, L.A., Fruehauf, J.P., and Mechetner, E., Analysis of P-Glycoprotein-Mediated Membrane Transport in Human Peripheral Blood Lymphocytes Using the UIC2 Shift Assay, Cytometry, 2003, vol. 53(2), pp. 67-78.
10. Akiyama, S., Fojo, A., Hanover, J.A., Pastan, I., and Gottesman, M.M., Isolation and Genetic Characterization of Human KB Cell Lines Resistant to Multiple Drugs, Somat. Cell Mol. Genet., 1985, vol. 11, pp. 117-126.
11. Batist, G., Tulpule, A., Sinha, B.K., Katkis, A.G., Myers, C.E., and Cowan, K.H., Overexpression of a Glutathione Transferase in Multidrug-Resistant Human Breast Cancer Cells, J. Biol. Chem., 1986, vol. 261(33), pp. 15544-15549.
12. Agapova, L.S., Ivanov, A.V., Sablina, A.A., Kopnin, P.B., Sokova, O.I., Chumakov, P.M., and Kopnin, B.P., P53-Dependent Effects of RAS Oncogene on Chromosome Stability and Cell Cycle Checkpoints, Oncogene, 1999, vol. 18(20), pp. 3135-3142.
13. Vaiman, A.V., Stronskaya, T.P., Rybalkina, E.Yu. Sorokin, A.V., Gurjanov, S.G., Zabotina, T.N., Mechetner, E.B., Ovchinnikov, L.P., and Stavrovskaya, A.A., Intracellular Localization and Content of YB-1 Protein in Multidrug Resistant Tumor Cells., Biochemistry (Moscow) (Rus.), 2006, vol. 71,(2), pp. 190-200.
14. Neshat, M.S., Mellinghoff, I.K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J.J., Wu, H., and Sawyers, C.L., Enhanced Sensitivity of PTEN-Deficient Tumors to Inhibition of FRAP/ mTOR, Proc. Natl. Acad. Sci. USA, 2001, vol. 98, pp. 10314-10319.
15. Grünwald, V., DeGraffenried, L., Russel, D., Friedrichs, W.E., Ray, R.B., and Hidalgo, M., Inhibitors of mTORr Reverse Doxorubicin Resistance Conferred by PTEN Status in Prostate Cancer Cells, Cancer Research, 2002, vol. 62, pp. 6141-6145.
16. David-Beabes, G.L., Overman, M.J., Petrofski, J.A., Campbell, P.A., de Marzo, A.M., and Nelson, W.G., Doxorubicin-Resistant Variants of Human Prostate Cancer Cell Lines DU 145, PC-3, PPC-1, and TSU-PR1: Characterization of Biochemical Determinants of Antineoplastic Drug Sensitivity, Int. J. Oncol., 2000, vol. 17, pp. 1077-1086.
17. Edinger, A.L., Linardic, C.A., Chiang, G.G., Thompson, C.B., and Abraham, R.T., Differential Effects of Rapamycin on Mammalian Target of Rapamycin Signaling Functions in Mammalian Cells, Cancer Research, 2003, vol. 63, pp. 8451-8460.
18. Vanderweele, D.J., Zhou, R., and Rudin, C.M., Akt Up-Regulation Increases Resistance to Microtubule-Directed Chemotherapeutic Agents through Mammalian Target of Rapamycin, Mol. Cancer. Ther., 2004, vol. 3(12), pp. 1605-1613.
19. Martelli, A.M., Tazzari, P.L., Tabellini, G., Bortul, R. Billi, A.M., Manzoli, L., Ruggeri, A., Conte, R., and Cocco, L., A New Selective Akt Pharmacological Inhibitor Reduces Resistance to Chemotherapeutic Drugs, TRAIL, All-trans-Retinoic Acid, and Ionizing Radiation of Human Leukemia Cells, Leukemia, 2003, vol. 17(9), pp. 1794-1805.
20. Recher, C., Beyne-Rauzy, O., Demur, C., Chicanne, G., Dos Santos, C., Mas, V.M., Benzaquen, D., Laurent, G., Huguet, F., and Payrastre, B., Antileukemic Activity of Rapamycin in Acute Myeloid Leukemia, Blood, 2005, vol. 105(6), pp. 2527-2534.
21. Mondesire, W.H., Jian, W., Zhang, H., Ensor, J., Hung, M.C., Mills, G.B., and Meric-Bernstam, F., Targeting Mammalian Target of Rapamycin Synergistically Enhances Chemotherapy-Induced Cytotoxicity in Breast Cancer Cells, Ensor. J. Clin. Cancer. Res., 2004, vol. 10(20), pp. 7031-7042.
22. Bing-Hua, Jiang and Ling-Zhi, Liu, Role of mTOR in Anticancer Drug Resistance: Perspectives for Improved Drug Treatment, Drug Resistance Updates, 2008, vol. 11, pp. 63-76.
23. Easton, J.B. and Houghton, P.J., mTOR and Cancer Therapy, Oncogene, 2006, vol. 25, pp. 6436-6446.